These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9001853)

  • 1. A disease management case study in infectious disease.
    Wert SM
    Clin Ther; 1996; 18(6):1366-73. PubMed ID: 9001853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratios.
    Conklin MH; Culley EJ; O'Donnell J
    J Manag Care Pharm; 2009; 15(1):55-61. PubMed ID: 19125550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
    Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
    BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital.
    John JF; Fishman NO
    Clin Infect Dis; 1997 Mar; 24(3):471-85. PubMed ID: 9114203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Econotherapeutics.
    Roark MK; Reed WE
    Diagn Microbiol Infect Dis; 1995; 22(1-2):209-17. PubMed ID: 7587042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.
    Bailey TC; Ritchie DJ; McMullin ST; Kahn M; Reichley RM; Casabar E; Shannon W; Dunagan WC
    Pharmacotherapy; 1997; 17(2):277-81. PubMed ID: 9085319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted evaluation of antibiotic regimen coverage and cost.
    Day D; Lubowski TJ; Yamaga CC; Main J; Van Vleet J; Ambegaonkar A
    Clin Ther; 1999 Aug; 21(8):1418-25. PubMed ID: 10485512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential antibiotic therapy: the right patient, the right time and the right outcome.
    Davey P; Nathwani D
    J Infect; 1998 Jul; 37 Suppl 1():37-44. PubMed ID: 9756368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare and outpatient therapy for infectious diseases.
    Wenzel RP; Nettleman MD
    Clin Infect Dis; 1998 Dec; 27(6):1422-3. PubMed ID: 9868654
    [No Abstract]   [Full Text] [Related]  

  • 11. Child-care practices: effects of social change on the epidemiology of infectious diseases and antibiotic resistance.
    Holmes SJ; Morrow AL; Pickering LK
    Epidemiol Rev; 1996; 18(1):10-28. PubMed ID: 8877328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effective approach to managing infectious disease.
    Wright RA
    Consultant; 1989 May; 29(5):143-6, 150, 155. PubMed ID: 10292917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of antibiotic treatment for priority infectious syndromes in Paraguay, 2004.
    Baez E; Dentice MA; Heitmann I
    Epidemiol Bull; 2005 Jun; 26(2):8-11. PubMed ID: 16578882
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team.
    Gums JG; Yancey RW; Hamilton CA; Kubilis PS
    Pharmacotherapy; 1999 Dec; 19(12):1369-77. PubMed ID: 10600085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dalfampridine prior authorization program: a cohort study.
    Gleason PP; Phillips J; Fenrick BA; Delgado-Riley A; Starner CI
    J Manag Care Pharm; 2013; 19(1):18-25. PubMed ID: 23383704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: How to encourage more diagnostics for infectious diseases.
    Powers JH
    BMJ; 2016 Sep; 354():i4744. PubMed ID: 27604999
    [No Abstract]   [Full Text] [Related]  

  • 17. Business aspects of infectious diseases.
    Tenenbaum MJ; Petrak R
    Clin Infect Dis; 2002 Feb; 34(3):420. PubMed ID: 11774093
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes.
    Gross R; Morgan AS; Kinky DE; Weiner M; Gibson GA; Fishman NO
    Clin Infect Dis; 2001 Aug; 33(3):289-95. PubMed ID: 11438891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed Medicaid cost savings: the Arizona experience.
    McCall N; Wrightson CW; Paringer L; Trapnell G
    Health Aff (Millwood); 1994 Spring (II); 13(2):234-45. PubMed ID: 8056377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks.
    McDonnell A; Rex JH; Goossens H; Bonten M; Fowler VG; Dane A
    Clin Infect Dis; 2016 Aug; 63 Suppl 2(Suppl 2):S57-9. PubMed ID: 27481955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.